The exotoxin of Vibrio cholerae (cholera toxin [CT] ) acting on receptors in the plasma membrane of epithelial cells of the small intestine is the agent causing the acute diarrhea of clinical cholera. The toxin consists of five identical B subunits which mediate binding to receptors and an enzymatically active A subunit which stimulates adenylate cyclase activity, thereby initiating an increase in the bodyto-lumen secretion (14, 25) . It is generally accepted that the monosialoganglioside GM1 is the toxin receptor in the intestine of several animal species including humans (6, 16, 19) . Recently, it has been shown that other gangliosides such as GDlb (8, 15, 23) , fucose-GM1 (18) , and galactose-N-acetylgalactosamine-GM1l (26) show considerable capacity to bind CT when assayed in vitro. Even if some of these latter gangliosides are also present in intestinal epithelial cells, a receptor capability leading to an increase in cyclic AMP concentration has not yet been demonstrated for any of them. It is conceivable that substances capable of binding CT but lacking the subsequent step of adenylate cyclase stimulation may sequester toxin from the medium and consequently prevent the clinical symptoms.
On the other hand, several epidemiological studies of cholera in recent years have demonstrated a predisposition of individuals with blood group 0 to be affected by the disease. From those studies it was not possible to get an insight on the molecular bases of these genetically related events; however, it was concluded that even though group 0 predisposes towards the disease, the blood group does not seem to affect the risk of an individual to be colonized with V. cholerae (2, 5, 12, 20) .
The aim of the present work was to search for pig intestinal compounds able to bind CT and to study their relationship with ABO blood group antigenicity employing * Corresponding author.
tissue from pigs carrying or not carrying blood group Aactive substances (A' and A-pigs, respectively).
MATERIALS AND METHODS Materials. CT, choleragenoid (B subunit), Ulex europaeus I lectin, sugars, fatty acid and sphingosine standards, Silica Gel G, Sephadex G-25/80, and DEAE-Sephadex A-50 were from Sigma Chemical Co. (St. Louis, Mo.). Precoated thinlayer chromatography (TLC) plates (Silica Gel 60) with aluminum backing were obtained from E. Merck AG (Darmstadt, Federal Republic of Germany).
Gangliosides GM1 and GDlb were isolated from bovine brain (24) . Glycolipid extracts from pig intestinal mucosa of a segment (3 m) from the middle portion of the small intestine were obtained from the upper phase after partitioning by the method of Folch et al. (9) and dialyzed for 48 h against distilled water. Na125I (17 mCi/,g) was from Radiochemical Centre (Amersham, United Kingdom). 125I-CT was prepared by the method of Cuatrecasas (6); the specific activity was 0.5 ,Ci/,ug. Human anti-A, anti-B, and anti-AB antisera were obtained from Ortho Diagnostics, Inc. (Raritan, N.J.). Protein A was prepared from Staphylococcus aureus (31) and was 1251I labeled by the chloramine-T method (17 tions of 10 ml were collected, the presence in each fraction of compounds able to bind CT was monitored by TLC, and fractions enriched in the different compounds were pooled ( Fig. 1 ). The major compound detected only in A' pigs (see . In every case, only one spot was visualized after the plate was sprayed with water or sulfuric acid and charred or by exposing the plate to iodine vapors. Chemical composition analysis. Fatty acid and carbohydrate analyses were done by gas-liquid chromatography (GLC) (1) . The sample (approximately 50 R,g) was subjected to methanolysis for 4 h at 100°C with' 1 ml of 3% (wt/wt) anhydrous methanolic hydrochloric acid. Fatty acid methyl esters were extracted with n-hexane, and samples were For long-chain base analysis, a sample was hydrolyzed with 1 ml of methanol-water-HCI (82:9.4:8.6, vol/vol/vol) for 24 h at 78°C. The hydrolysate was made alkaline with 1 N sodium hydroxide, the sphingosine bases were then extracted with ethyl ether, and the solvent was evaporated under a stream of nitrogen. The residue dissolved in chloroform-methanol (1:1) was spotted on a TLC plate and developed with chloroform-methanol-2 N ammonia (40:10:1). The spots were visualized with the ninhydrin reagent (0.2 g of ninhydrin in 100 ml of acetone) after heating at 105°C for 1 min (30) .
RESULTS
Binding of CT to glycolipid extracts from pig intestinal mucosa cells. Glycolipids obtained from the upper phase after Folch partitioning (9) of a pool of pig intestinal mucosa and resolved by TLC revealed the presence of six to eight compounds capable of binding 1251I-CT, two of them running as the ganglioside standards GM1 and GDlb (Fig. 2, lanes 5 and 6). Preincubation of the TLC strips in the dipping buffer containing unlabeled B subunit (20 times in excess of labeled CT) for 30 min resulted in a complete inhibition of the 125I-CT binding (Fig. 2, lane 2) . The binding was also suppressed if the 125I-CT was preincubated with GM1 (1:20 molar ratio) for 20 min at room temperature (Fig. 2, lane 1) .
Similar results were obtained with GM1 and GDlb standards (Fig. 2, lanes 3 and 4) .
When intestinal mucosa glycolipids from single pigs were assayed by TLC for CT-binding capacity, two clearly different patterns of labeling were observed. The main differ- Fig. 1 ). Lane 4, Ganglioside standards (50 pmol of GDlb and 5 pmol of GM1). The TLC solvent system was as described in the legend to Fig. 1. ences between patterns were at the level ofcompounds running below GDlb (Fig. 3, lanes 1 and 2) . To explain these differences and taking into account the susceptibility of a person to develop cholera in relation to the ABO blood group, we investigated the blood antigenic properties of individual pigs.
Relationship (Fig. 1, compound f) .
This compound was eluted from the DEAE-Sephadex column with choloroform-methanol-water (30:60:8), indicating the absence of a net negative charge. This property was confirmed by passing a mixture of compound f, GM1, and GDlb through the ion-exchange column; the gangliosides were eluted at the expected ammonium formate concentration (28) . The compound gave a blue color on TLC when revealed with the orcinol-sulfuric acid reagent, indicating the presence of sugars (32), but was not detected with the resorcinol-HCl reagent (37) . In addition, after acid hydrolysis (0.1 N HCl, 80°C, 120 min), the compound did not change (Fig. 5) .
To evaluate the specificity of the immunoreaction to label the compound on TLC, commercial anti-A, anti-B, and anti-AB antisera were used at the same dilution (1:10) and hemagglutination titer. The spot on the autoradiograph was observed in the strips treated with anti-A or anti-AB antiserum but not with anti-B antiserum (Fig. 4) . Occasionally, as observed in Fig. 4 , the purified glycolipid behaved on TLC as a doublet. In these cases, the split compound could be detected with either CT or anti-A antiserum. The label was stronger with the anti-AB antiserum than with the anti-A antiserum; this different avidity between the antisera is a well-known serological phenomenon (13) . Under similar conditions, GM1 and GDlb standards gave negative results, eliminating the possibility of a nonspecific reaction (data not shown). The purified compound was also able to inhibit the 2) or anti-AB blood group antiserum-251I-protein A (lanes 3) to the following compounds: lanes 2 and 3, purified compound f (Fig. 1) ; lanes 1, GM, and GDlb standards (5 and 50 pmol, respectively). TLC solvent mixtures were n-propanol-water (70:30) (A), chloroform-methanol-hemagglutination of human A erythrocytes caused by anti-A antiserum, but inhibition was not observed with the B-anti-B or 0 (H)-U. europaeus lectin systems. Under the conditions used (33), the A activity of the compound was approximately 0.15 nmol/0.1 ml (see below). This activity is similar to that described for other A-active fucolipids of pig gastric mucosa (33) .
A partial chemical characterization of compound f indicated that it is a glycosphingolipid. After acid hydrolysis, extraction with ethyl ether, and TLC (30), ninhydrin-positive substances running as sphingosine and phytosphingosine standards were detected. A similar pattern of ninhydrinstaining compounds was observed by processing under the same conditions a bovine brain GM1 standard except for the absence of phytosphingosine. Phytosphingosine is frequently present in intestinal glycosphingolipids of many animal species (27, 35) . Fatty acid and carbohydrate analyses were done by GLC. About 70% of the fatty acids showed retention times the same as the corresponding standards, giving the following relative distribution: 16:0, 20.3%; 16:1, 10.4%; 18:0, 13.7%; 18:1, 25.4%; several unidentified peaks accounted for the difference. A sample of bovine brain ganglioside GM1 run under identical conditions gave the expected fatty acid composition (16:0, 4%; 18:0, 95%; 20:0, 1%). The sugar analysis revealed the presence of glucosefucose-galactose in a molar ratio of 1:1:2 and hexosamine in a quantity not yet determined. Standard GM1 gave the expected neutral sugar molar ratio, but hexosamine could not be quantified. There are many reports describing difficulties in the determination of trimethylsilyl derivatives of hexosamines by gas-liquid chromatography (35, 38) . As the limited amount of purified glycosphingolipid available is an inconvenience for chemical analysis by techniques that are relatively insensitive, experiments employing physicochemical methods requiring small amounts of sample are in progress to determine the chemical structure of the compound.
On the basis of the fatty acid quantitation (assuming one fatty acid residue per glycosphingolipid molecule), the estimated amount of compound f from a pool of five A' pigs is approximately 1.0 nmol/g (wet weight) of intestinal mucosa cells. When individual A' pig intestines were compared, considerable quantitative variations in the TLC patterns of compounds capable of binding either CT or anti-AB antiserum were observed on the basis of tissue wet weight.
To evaluate the relative CT-binding capacity of compound f with respect to GM1 and GDlb, we performed a semiquantitative dot binding assay for the glycosphingolipids adsorbed on Silica Gel 60-precoated plates. By this method, the binding capacity of compound f was practically equal to that of GDlb and approximately 10 times lower than that of GM1 (Fig. 6) . A similar difference for CT-binding affinity between GM1 and GDlb, about 10 times, determined by a quantitative solid-phase radioimmunoassay has recently been reported (10) . DISCUSSION The main contribution described in this report is the finding in pig intestinal mucosa of a neutral glycosphingolipid containing fucose which has the property to bind CT and to be recognized by anti-human blood group A antiserum. A compound with these characteristics has not been described before. The existence in the gastrointe'stinal tract of blood group-active glycoconjugates able to interact with CT may be important from a physiopathological point of view since the presence or absence of such compounds in an individual is genetically determined. Our results with individual intestinal mucosa showed a clear correlation between the occurrence of certain blood group-active substances in the pigs and the presence or absence of the glycosphingolipid that interacts with CT. This glycolipid is detected in A' pigs but not in A-pigs. However, not all compounds detected by the anti-A antiserum have the ability to bind CT, i.e., compounds running faster than GM1 (Fig. 3) .
Epidemiological studies indicate a relationship between ABO blood groups and diarrheal disease caused by infection with V. cholerae. Persons belonging to blood group 0 were twice as likely to have severe diarrhea than community controls, while those with blood group A, B, or AB were less frequently affected (2, 5, 12, 20) . The gastrointestinal tract is especially rich in blood group substances (22) . The determinants are present in glycosphingolipids and glycoproteins (mucins) in epithelial cells, and the latter are secreted into the tissue fluids of about 80% of the population (11) . These individuals, known as secretors, possess a secretor gene which is independent of the ABO blood group systen. It is relevant that commercial pig gastric mucins, which are rich in blood group A antigens, premixed with CT inhibited the action of the toxin in rat intestinal loops, suggesting the presence in this mucin preparation of substances able to interact with CT. Mucins from other animal species and different organs were without effect (36) . Preliminary results from our laboratory (C. G. Monferran et al., unpublished data) indicate that the oligosaccharide moiety (34) of a delipidated mucin preparation (36) from an A' pig was a more potent inhibitor of CT binding than an equivalent preparation from an A-pig in a system utilizing rat erythrocyte membranes (29) . Studies of the possible role of blood group secretory substances in the etiology of cholera gave contrasting results. Chaudhuri and DasAdhikary (4) de-scribed a significant prevalence of nonsecretors among patients with cholera, while no difference was found in another study (12) . Unfortunately, in these reports the ABO blood group of the individuals was not taken into account; perhaps a more consistent conclusion could be found if both inherited characters, secretor status and blood group, were considered simultaneously. At present, we do not know whether any blood group-active substance capable of binding to CT exists in the human gastrointestinal tract, and obviously, an extrapolation of the present results is premature. However, it is possible that some relationship could exist between blood group antigens and CT in the etiology of cholera. Our working hypothesis is that individuals with blood group 0 show a predisposition toward the disease owing to a deficit of some compound(s) with antigenic properties of blood group A or B or both (mucins?) able to interact with CT and therefore preventing binding to the membrane receptors. Accordingly, the prevalence of the secretor gene will not be significantly different between cholera patients and controls in individuals with blood group 0. Conversely, persons with blood group A or B carrying the secretor gene will have a lesser risk of being affected by the disease.
